MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s13023-021-02090-y

Медицинская библиотека · Orphanet journal of rare diseases · 2021

A multicenter cross-sectional French study of the impact of COVID-19 on neuromuscular diseases.

Pisella Lucie Isoline, Fernandes Sara, Solé Guilhem, Stojkovic Tanya, Tard Céline, Chanson Jean-Baptiste, Bouhour Françoise, Salort-Campana Emmanuelle, Beaudonnet Guillemette, Debergé Louise, Duval Fanny, Grapperon Aude-Marie, Masingue Marion, Nadaj-Pakleza Aleksandra, Péréon Yann, Audic Frédérique, Behin Anthony, Friedman Diane, Magot Armelle, Noury Jean-Baptiste, Souvannanorath Sarah, Wahbi Karim, Antoine Jean-Christophe, Bigaut Kévin, Camdessanché Jean-Philippe, Cintas Pascal, Debs Rabab, Espil-Taris Caroline, Kremer Laurent, Kuntzer Thierry, Laforêt Pascal, Laugel Vincent, Mallaret Martial, Michaud Maud, Nollet Sylvain, Svahn Juliette, Vicart Savine, Villar-Quiles Rocio Nur, Desguerre Isabelle, Adams David, Segovia-Kueny Sandrine, Merret Géraldine, Hammouda Elhadi, Molon Annamaria, Attarian Shahram

СтатьяМногоцентровое исследованиеПеревод пока не подготовлен

Аннотация

BACKGROUND

Due to their health condition, patients with neuromuscular diseases (NMD) are at greater risk of developing serious complications with COVID-19. The objective of this study was to analyze the prevalence of COVID-19 among NMD patients and the risk factors for its impact and severity during the first wave of the pandemic. Clinical data were collected from NMD-COVID-19 patients, between March 25, 2020 and May 11, 2020 in an anonymous survey carried out by expert physicians from the French Health Care Network Filnemus.

RESULTS

Physicians reported 84 patients, including: 34 with myasthenia gravis, 27 with myopathy and 23 with neuropathy. COVID-19 had no effect on NMD for 48 (58%) patients and 48 (58%) patients developed low COVID-19 severity. COVID-19 caused the death of 9 (11%) NMD patients. Diabetic patients were at greater risk of dying. Patients with diabetes, hypertension or severe forms of NMD had a higher risk of developing a moderate or severe form of COVID-19. In our cohort, corticosteroids and other immunosuppressants were not significantly associated with higher COVID-19 severity for acquired NMD.

CONCLUSION

During this period, a small percentage of French NMD patients was affected by COVID-19 compared to the general French population and COVID-19 had a limited short-term effect on them. Diabetes, hypertension and a severe degree of NMD were identified as risk factors of unfavorable outcome following COVID-19. Conversely, in our cohort of patients with acquired NMD, corticosteroids or other immunosuppressants did not appear to be risk factors for more severe COVID-19.

Для цитирования: Pisella Lucie Isoline, Fernandes Sara, Solé Guilhem, Stojkovic Tanya, Tard Céline, Chanson Jean-Baptiste, Bouhour Françoise, Salort-Campana Emmanuelle, Beaudonnet Guillemette, Debergé Louise, Duval Fanny, Grapperon Aude-Marie, Masingue Marion, Nadaj-Pakleza Aleksandra, Péréon Yann, Audic Frédérique, Behin Anthony, Friedman Diane, Magot Armelle, Noury Jean-Baptiste, Souvannanorath Sarah, Wahbi Karim, Antoine Jean-Christophe, Bigaut Kévin, Camdessanché Jean-Philippe, Cintas Pascal, Debs Rabab, Espil-Taris Caroline, Kremer Laurent, Kuntzer Thierry, Laforêt Pascal, Laugel Vincent, Mallaret Martial, Michaud Maud, Nollet Sylvain, Svahn Juliette, Vicart Savine, Villar-Quiles Rocio Nur, Desguerre Isabelle, Adams David, Segovia-Kueny Sandrine, Merret Géraldine, Hammouda Elhadi, Molon Annamaria, Attarian Shahram. A multicenter cross-sectional French study of the impact of COVID-19 on neuromuscular diseases.. Orphanet journal of rare diseases. 2021. DOI: 10.1186/s13023-021-02090-y.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.